AZN is expected to report earnings to rise+33% to 96 cents per share on April 25

A.I.dvisor
at Tickeron.com
04/24/24
Loading...
AZN - AstraZeneca PLC
AstraZeneca PLC Earnings Graph
Q1'24
Est.
$0.96
Q4'23
Missed
by $0.01
Q3'23
Beat
by $0.87
Q2'23
Beat
by $1.16
Q1'23
Beat
by $0.11
The last earnings report on December 31 showed earnings per share of 73 cents, missing the estimate of 73 cents. P/B Ratio (5.325) is normal, around the industry mean (5.632). P/E Ratio (35.297) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.870) is also within normal values, averaging (3.004). Dividend Yield (0.022) settles around the average of (0.164) among similar stocks. P/S Ratio (4.585) is also within normal values, averaging (3.643). With 5.81M shares outstanding, the current market capitalization sits at 208.98B.
View a ticker or compare two or three
AZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
89900
Web
https://www.astrazeneca.com